Unique ID issued by UMIN | UMIN000048609 |
---|---|
Receipt number | R000055379 |
Scientific Title | Effects of consumption of the test food on the oral environment in healthy subjects: a randomized, placebo-controlled, double-blind, parallel-group comparison study |
Date of disclosure of the study information | 2022/08/05 |
Last modified on | 2022/09/30 12:26:10 |
Effects of consumption of the test food on the oral environment in healthy subjects
Effects of consumption of the test food on the oral environment in healthy subjects
Effects of consumption of the test food on the oral environment in healthy subjects: a randomized, placebo-controlled, double-blind, parallel-group comparison study
Effects of consumption of the test food on the oral environment in healthy subjects
Japan |
Healthy Japanese subjects
Not applicable | Adult |
Others
NO
To verify the effect of consumption of the test food on the oral environment in healthy Japanese subjects
Efficacy
Confirmatory
Pragmatic
Not applicable
1. The measurement value of halitosis {brilliant breath (B/B) value in B/B checker}
1. Subjective symptom measured by visual analogue scale (an original questionnaire)
2. The volume of saliva
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
Institution is not considered as adjustment factor.
2
Treatment
Food |
Duration: Two weeks
Test food: Lactic acid bacteria and yeast-chewable tablet (yogurt flavor)
Administration: Take one tablet twice per day within 3-5 minutes (as long as possible) without chewing right after each toothbrushing in the morning and evening
*If you forget to lick the test food, take it as soon as you remember. Daily dose should be taken within the day and not carried over to the next day.
Duration: Two weeks
Test food: Placebo chewable tablet
Administration: Take one tablet twice per day within 3-5 minutes (as long as possible) without chewing right after each toothbrushing in the morning and evening
*If you forget to lick the test food, take it as soon as you remember. Daily dose should be taken within the day and not carried over to the next day.
18 | years-old | <= |
Not applicable |
Male and Female
1. Japanese
2. Men or women
3. Adults
4. Healthy subjects
5. Subjects who are concerned about their halitosis
6. Subjects who are concerned about their oral sticky
7. Subjects who are concerned about their oral dryness
8. Subjects whose measurement value of halitosis is relatively high
1. Subjects who are undergoing medical treatment or have a medical history of malignant tumor, heart failure, and myocardial infarction
2. Subjects who have a pacemaker or an implantable cardioverter defibrillator (ICD)
3. Subjects who currently undergoing treatment for any of the following chronic disease: cardiac arrhythmia, liver disorder, kidney disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension, or any other chronic diseases
4. Subjects who use or take "Foods for Specified Health Uses," or "Foods with Functional Claims" in daily
5. Subjects who are currently taking medications (including herbal medicines) and supplements
6. Subjects who are allergic to medicines and/or the test food related products
7. Subjects who are pregnant, lactation, or planning to become pregnant during this trial
8. Subjects who suffer from COVID-19
9. Subjects who have been enrolled in other clinical trials within the last 28 days before the agreement to participate in this trial or plan to participate another trial during this trial
10. Subjects who are judged as ineligible to participate in this study by the physician
11. Subjects who use artificial tooth, post crowns, dentures, implants or bridges
12. Subjects who regularly use gargle medicine or mouthwash
13. Subjects who have a medical history or current history of Sjogren's syndrome, or who are suspected it
14. Subjects who have diseases associated with salivary gland such as dry mouse and salivary stone disease
15. Subjects who are undergoing medical treatment for periodontosis or dental caries
16. Subjects who are dental treatment or have dental diseases
17. Subjects who are smokers, or started smoking cessation within one year before the agreement to participate in this trial
30
1st name | Masahiko |
Middle name | |
Last name | Horiuchi |
Medical Corporation Yuseikai, Horiuchi Dental Clinic
Director
141-0022
2F AM Bldg., 2-3-3, Higashi-gotanda, Shinagawa-ku, Tokyo, Japan
03-3449-1033
dr_horiuchi@orthomedico.jp
1st name | Naoko |
Middle name | |
Last name | Suzuki |
ORTHOMEDICO Inc.
R&D Department
112-0002
2F Sumitomo Fudosan Korakuen Bldg., 1-4-1, Koishikawa, Bunkyo-ku, Tokyo, Japan.
03-3818-0610
nao@orthomedico.jp
ORTHOMEDICO Inc.
Maikon no kohara Corporation.
Profit organization
Medical Corporation Seishinkai, Takara Clinic
Nerima Medical Association, Minami-machi Clinic
Medical Corporation Yuseikai, Horiuchi Dental Clinic
the ethical committee of the Takara Clinic, Medical Corporation Seishinkai
9F Taisei Building, 2-3-2, Higashi-gotanda, Shinagawa-ku, Tokyo, Japan.
03-5793-3623
IRB@takara-clinic.com
NO
医療法人社団盛心会 タカラクリニック (東京都)
Medical Corporation Seishinkai, Takara Clinic (Tokyo, Japan)
南町医院 (東京都)
Nerima Medical Association, Minami-machi Clinic (Tokyo, Japan)
医療法人社団優正会 堀内歯科医院 (東京都)
Medical Corporation Yuseikai, Horiuchi Dental Clinic (Tokyo, Japan)
2022 | Year | 08 | Month | 05 | Day |
Unpublished
34
No longer recruiting
2022 | Year | 07 | Month | 20 | Day |
2022 | Year | 07 | Month | 20 | Day |
2022 | Year | 08 | Month | 05 | Day |
2022 | Year | 10 | Month | 30 | Day |
2022 | Year | 08 | Month | 05 | Day |
2022 | Year | 09 | Month | 30 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000055379
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |